相关实验视频
Updated: Jan 15, 2026

Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
前列腺癌和骨质疏松症之间的相互关系:关于共享分子通路和治疗策略的新视角
Zesong Jiang1,2, Junwen Zhang1,2, Zhongjian Qiu1,2
1Department of Urology, Affiliated Hospital of Jining Medical University, Jining, Shandong, China.
前列腺癌患者经常患有骨质疏松症,原因是衰老,炎症和瘤因素,而不仅仅是抗雄激素剥夺疗法 (ADT). 像RANKL/RANK/OPG这样的共享路径提供了双重治疗目标.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 骨生物学 骨生物学 骨生物学
背景情况:
- 骨质疏松症在前列腺癌患者中很常见,即使没有抗雄激素剥夺疗法 (ADT).
- 诸如衰老,炎症和瘤特征等因素有助于这些患者的骨质损失.
- 现有研究尚未充分探索前列腺癌和骨质疏松症之间的共同分子机制.
研究的目的:
- 为了阐明骨质疏松症和前列腺癌之间的相互作用.
- 综合分析这两种情况所涉及的共享信号通路.
- 评估前列腺癌患者目前的骨质疏松症预防策略.
主要方法:
- 文献综述,重点关注共享的分子通路.
- 分析包括RANKL/RANK/OPG,Wnt,CXCL12/CXCR4,TGF-β和IGF-1在内的信号通路.
- 对前列腺癌骨质疏松症的治疗策略的评估.
主要成果:
- 共享的信号通路 (RANKL/RANK/OPG,Wnt,CXCL12/CXCR4,TGF-β,IGF-1) 在前列腺癌和骨质疏松症中都非常重要.
- 这些途径代表了两种疾病同时治疗的潜在目标.
- 针对这些途径的新兴双重作用剂显示出有前途.
结论:
- 前列腺癌和骨质疏松症有着共同的分子路径.
- 针对这些途径可能会导致双重治疗的新型治疗策略.
- 对双重作用药物的进一步研究是有必要的,以改善患者的治疗结果.
更多相关视频
06:32Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
Published on: November 4, 2022
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Bone Remodeling